Bresat Cancer Update
Oncology Leader CommentarySpecial FeaturesPrevious Issues

Home: Meeting Highlights

Posters
2000 NIH Consensus Statement
on Adjuvant Therapy

2001 Meeting Interactive Report
2000 Meeting Interactive Report
Current Breast Cancer Clinical Trials


The 18th Annual Miami Breast Cancer Conference, held February 28 through March 3, 2001, featured an educational supplement to enhance the meeting. The supplement includes a summary of clinical trials, posters, a copy of the 2000 NIH Consensus Statement on Adjuvant Therapy of Breast Cancer, and results of the interactive questions from the 2000 conference with commentary from Dr’s Andrew Seidman and Patrick Borgen from Memorial Sloan-Kettering Cancer Center. Click below to view these educational components.

Editor's Note

New Twists for 2001

Dan Osman’s guiding principal for almost two decades of directing the Miami Breast Cancer Conference has been, "What can you learn from this conference that you can use Monday morning, and what can you look forward to on Friday?" He explains that, "We always ask our speakers to address the toughest clinical situations and tell our audience how they would manage such patients, but we also want to help the registrants see what’s coming down the pike over the next few years. Doctors attending our conference enjoy that because they inherently know there’s a new shift in thinking on breast cancer management."

This educational supplement reflects the juxtaposition of cutting-edge research information and emerging new interventions that imbue our meeting. The clinical trials guide organizes almost 200 breast cancer studies currently listed by the National Cancer Institute and provides contact information for physicians who wish to enter patients. While many practicing clinicians do not have the time to participate in clinical research, understanding the background for these studies and the rationale for trial designs can provide valuable insight into future directions for breast cancer treatment. We also hope that by outlining the very worthwhile objectives of these studies, more physicians will be motivated to enter patients or refer them for trial accrual. Currently, a disappointing three percent of breast cancer patients are entered in clinical trials. During the meeting, a special panel of clinical investigators will discuss some of the most important ongoing studies and the complex challenges trialists face in accruing patients.

A relatively recent part of the "What can be used on Monday?" theme is the meeting’s use of clinical interactive keypad questions, which we have now utilized for the last four conferences. Dan notes that, "It took us a couple of years to really understand how to use this technology, but our attendees have evaluated this very favorably. This year, it should be even more effective because we are interacting very closely with the faculty prior to the meeting to develop really challenging questions." Because of many requests for copies of the entire set of questions and responses, and for expert commentary on these issues, we produced the enclosed report from the 2000 meeting with comments from Memorial Sloan-Kettering’s Dr Pat Borgen and Dr Andy Seidman, who were on the faculty of last year’s meeting. For 2001, we will be mailing a similar report to all attendees several weeks after the conference. Another enhancement in this year’s interactive program will be cases that utilize short video comments from breast cancer survivors. Often medical meetings do not include the human elements that physicians encounter in clinical decision-making, and our intent is to introduce this concept with these video cases.

Andrew Seidman, MD, (left) and Patrick Borgen, MD, (right)
discuss interactive cases in the enclosed report

Another innovation for the current meeting is our first-ever poster session/reception. For attendees not able to participate, we have included copies in this supplement, and the posters will also be on display throughout the meeting in the Poinciana Room, adjacent to the main meeting area. In keeping with our practical clinical approach, many of the posters are academic reviews of rapidly developing clinical areas, where the research database is exploding. A number of the posters were prepared by fellows in surgical, medical and radiation oncology who are attending the meeting on a scholarship program that was launched last year. Dan commented that, "Fellows often have a very narrow exposure to the philosophic approaches of the institutions where they trained. I believe their education would be enhanced if they were exposed to our diverse international faculty and attendees. We have had a fantastic response to our scholarship program, and for 2002, we want to see these physicians become even more involved in the poster session."

"Breast Cancer Web Tour" is reviewed at a monthly
directors planning meeting.
From left: Daniel Osman, MD; Neil Love, MD;
Lois Osman and Robert DerHagopian, MD.
(not pictured: Alan Lewin, MD)

Finally, this year we are bringing more Internet-based education into the meeting because of the enormous potential this vehicle has to provide information. Dan notes that, "More senior people like myself need to develop a greater comfort level with the Internet. I’m continuing to learn about it, but what I’ve seen is very exciting." The "Breast Cancer Update" exhibit area (based on our audio series) has a number of computers with high-speed Internet access, which attendees can use during the meeting to visit sites on a special "Breast Cancer Web Tour" that was set up for this meeting. All of the enclosed material in this supplement is also available via the meeting website (CancerConf.com) and on BreastCancerUpdate.com.

Michelle Finkelstein, MD, (left) interviews a breast cancer survivor for a video case presentation.

The classic research model of developing a hypothesis and then objectively evaluating it can also be applied to cancer education. To that end, the back cover of this binder includes an education needs assessment that asks for feedback on this supplement and the new additions to the 2001 conference, which we hope will enhance your effectiveness on "Monday" and your understanding of what to expect on "Friday."

—Neil Love, MD

Top of Page

Home · Contact us
Terms of use and general disclaimer